Bal Pharma Ltd.
Fundamentals
- Market cap
- ₹154 cr
- P/E
- 18.90×
- ROE
- 9.32%
- Debt / equity
- 1.94
- Div yield
- 1.30%
- 52-week range
- 60.00 — 111.18
The timeline — 2 notes on Bal Pharma Ltd.
May 2026
- 27 May 26 · 6:55 PM IST Brief Brief · Earnings · Micro cap
Bal Pharma profit drops 34% as board approves promoter warrant issue
Standalone net profit fell to ₹3.70 crore in Q4, while the board cleared a preferential issue of 1,000,000 warrants to promoters.
- 27 May 26 · 6:48 PM IST Brief Brief · Earnings · Micro cap
Bal Pharma profit slips 34% as board approves promoter warrants
The pharmaceutical company reported a Q4 net profit of ₹3.70 crore, down from ₹5.61 crore in the same period last year.